Efficacy of perioperative 2% dorzolamide ophthalmic solution for reduction of postoperative ocular hypertension in dogs following routine phacoemulsification surgery: A prospective clinical trial.
Andrew Christopher LewinJennifer HuChin-Chi LiuPilar CamachoRenee T CarterPublished in: Veterinary ophthalmology (2023)
Perioperative administration of topical 2% dorzolamide reduced the incidence of POH after phacoemulsification in the dogs studied. However, this was not associated with differences in visual outcome, incidence of glaucoma or need for IOP-lowering medications.
Keyphrases
- patients undergoing
- clinical trial
- cataract surgery
- risk factors
- cardiac surgery
- blood pressure
- minimally invasive
- optic nerve
- coronary artery bypass
- solid state
- double blind
- randomized controlled trial
- open label
- surgical site infection
- phase ii
- coronary artery disease
- acute kidney injury
- acute coronary syndrome
- atrial fibrillation